Demonstrates the role of protein kinase C in modifying hormonal inhibition in cells, suggesting new avenues for understanding signal transduction.
Human platlet membrane proteins were phosphorylated by exogenous, partially purified Ca 2+ ‐activated phospholipid‐dependent protein kinase (protein kinase C. the phosphorylation of one of the major substrates fro protein kinase C ( M r = 41000) wa specifically suppressed by the β subunit of the inhibitory guaninenucleotide‐binding regulatory component (G 1 , N i ) of adenylate cyclase. The free α subunit of G i ( M r = 41000) also served as an excellent substrate for the kinase (<0.5 mol phosphate incorporated per mol of subunit), but the G i oligomer (α·β·γ) did not. Treatment of cyc ‐ S49 lymphoma cells, which are dificient in G s /N s (the stimulatory component) but contain functional G i /N s , with the phorbol ester, 12‐ O ‐tetradecanoylophorbol 13‐acetate, a potent activator of protein kinase C, did not alter stimulation of adenylate cyclase catalystic activity by forskolin, whereas the G i /N i ‐mediated inhibition of the cyclase by the hormone, somatostatin, was impaired in these membranes. The results suggest that the α subunit of the inhibitory guanine‐nucleotide‐binding regulatory component of adenylate cyclase may be a physiological substrate for protein kinase C and that the function of the component in transducing inhibitory hormonal signals to adenylate cyclase is altered by its phosphorylation.
No takes yet. Share an insight, caveat, or question.
Katada et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: